Search Results
FMTS, Université de Strasbourg, Faculté de Médecine, France
Search for other papers by Bernard Goichot in
Google Scholar
PubMed
Search for other papers by François Lefebvre in
Google Scholar
PubMed
Search for other papers by Stéphane Vinzio in
Google Scholar
PubMed
Search for other papers by Anne Cailleux in
Google Scholar
PubMed
Search for other papers by Jean-Marc Kuhn in
Google Scholar
PubMed
Search for other papers by Olivier Schneegans in
Google Scholar
PubMed
Search for other papers by Bodgan Catargi in
Google Scholar
PubMed
Search for other papers by Olivier Gilly in
Google Scholar
PubMed
Search for other papers by Philippe Baltzinger in
Google Scholar
PubMed
iCUBE, CNRS UMR, Illkrich, France
Search for other papers by Nicolas Meyer in
Google Scholar
PubMed
Université Paul Sabatier, Inserm, Toulouse, France
Search for other papers by Philippe Caron in
Google Scholar
PubMed
Search for other papers by the investigators of the Pirahtes study † in
Google Scholar
PubMed
Introduction Subclinical hyperthyroidism (SCH) emerged as a concept in the 1980s with the availability of ultra-sensitive, or second generation, thyroid-stimulating hormone (TSH) assays ( 1 , 2 , 3 , 4 ). SCH is biochemically defined by a
Search for other papers by Nianting Ju in
Google Scholar
PubMed
Search for other papers by Liying Hou in
Google Scholar
PubMed
Search for other papers by Hongjun Song in
Google Scholar
PubMed
Search for other papers by Zhongling Qiu in
Google Scholar
PubMed
Search for other papers by Yang Wang in
Google Scholar
PubMed
Search for other papers by Zhenkui Sun in
Google Scholar
PubMed
Search for other papers by Quanyong Luo in
Google Scholar
PubMed
Search for other papers by Chentian Shen in
Google Scholar
PubMed
have a good prognosis due to the biological behavior and standard treatments. Three conventional treatment regimens for thyroid cancer are surgery, radioiodine ( 131 I) therapy, and thyroid-stimulating hormone (TSH) suppression. Among them, 131 I is
Search for other papers by Andrea Leoncini in
Google Scholar
PubMed
Search for other papers by Chiara Camponovo in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland
Search for other papers by Gaetano Paone in
Google Scholar
PubMed
Search for other papers by Elena Gamarra in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland
Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
Search for other papers by Giorgio Treglia in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland
Search for other papers by Pierpaolo Trimboli in
Google Scholar
PubMed
to biopsies that yield a final benign cytological/histological outcome. The lower the rate of UN-FNAC, the higher the reliability of TIRADS ( 6 ). Autonomously functioning thyroid nodule (AFTN) is a thyroid nodule that can produce hormones
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
be the preferred method of preparation for RAI administration. Remnant ablation has historically been performed after prolonged l-T4 withdrawal to increase endogenous thyroid-stimulating hormone (TSH) to levels sufficient to induce robust RAI uptake
Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Min Gyu Kim in
Google Scholar
PubMed
Search for other papers by Min Soo Kim in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
the following hematological test values that could be measured before surgical treatment were evaluated: free thyroxine (fT4), thyroid stimulating hormone (TSH), thyroglobulin (Tg), anti-Tg antibody (Ab), and anti-thyroid peroxidase (TPO) Ab
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Junyu Tong in
Google Scholar
PubMed
Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
Search for other papers by Maomei Ruan in
Google Scholar
PubMed
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Hao Fu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Qiong Luo in
Google Scholar
PubMed
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Zhiyan Liu in
Google Scholar
PubMed
Search for other papers by Zhongwei Lv in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
the lesions show potential ability of uptaking 131 I, but the therapeutic effect is not ideal. This may be ascribed to an impaired thyroid hormone synthesis system, yielding shortened 131 I retention time and reduced radiation dose, which might be
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Pitoia F Abelleira E & Cross G . Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH . Endocrine 2017 55 200
Search for other papers by Marine Sitbon in
Google Scholar
PubMed
Search for other papers by Porhuoy Chou in
Google Scholar
PubMed
Search for other papers by Seydou Bengaly in
Google Scholar
PubMed
Search for other papers by Brigitte Poirot in
Google Scholar
PubMed
Search for other papers by Marie Laloi-Michelin in
Google Scholar
PubMed
Search for other papers by Laure Deville in
Google Scholar
PubMed
Search for other papers by Atanas Pachev in
Google Scholar
PubMed
Search for other papers by Ahouefa Kowo-Bille in
Google Scholar
PubMed
Search for other papers by Clement Dumont in
Google Scholar
PubMed
Search for other papers by Cécile N Chougnet in
Google Scholar
PubMed
endocrine secretions of carcinomas can be life-threatening. Medullary thyroid carcinoma (MTC) is a rare cancer that is often responsible not only for hormone secretion, mainly calcitonin secretion, but also possibly adrenocorticotrophic hormone (ACTH
Search for other papers by Inês Cosme in
Google Scholar
PubMed
Search for other papers by Ana Figueiredo in
Google Scholar
PubMed
Search for other papers by Sara Pinheiro in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction The incidence of thyroid carcinoma (TC) increased over the past 50 years ( 1 , 2 ) mainly due to a disproportionate increase in small papillary TC ( 3 ). In 2020, the GLOBOCAN database reported worldwide 586,000 cases of TC
Search for other papers by Daniela Cavaco in
Google Scholar
PubMed
Search for other papers by Ana Filipa Martins in
Google Scholar
PubMed
Search for other papers by Rafael Cabrera in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
surgery (under recombinant thyroid-stimulating hormone (TSH) or L-thyroxine withdrawal). Periodic follow-up included, at least, TSH, thyroglobulin (Tg), and antithyroglobulin (anti-Tg) antibody determination, as well as neck US. Other imaging and